Chertkow, Howard M

Purpose

The main objectives of CCNA Phase III (Operations Centre and CCNA Research teams) align with and build upon Phases I and II: • Increase the interdisciplinary collaborations within and across Teams, Themes and the Operations Centre in the area of age-related neurodegenerative diseases having an impact on cognition, including, but not limited to, prevention and risk reduction, diagnosis, treatment, care, services and social aspects; • Build capacity in age-related neurodegenerative diseases that have an impact on cognition, including, but not limited to: prevention and risk reduction, diagnosis, treatment, care, services, social aspects, while recognizing, integrating and addressing equity, diversity and inclusion considerations, First Nations, Inuit and Métis health perspectives and persons with living/lived experience; and, • Enhance the competitiveness of researchers in Canada, their international presence and influence on outcomes related to neurodegenerative diseases affecting cognition. The specific objectives of the CCNA Operations Centre funding opportunity are to: • Optimize a national operations centre to provide leadership, strengthen, and synergize innovative and collaborative Canadian research in neurodegenerative diseases; • Provide guidance and coordination efforts for training and capacity development, to foster career development of the next generation of researchers in the field; • Enhance the capacity for knowledge mobilization (KM) in both official languages to increase the dissemination and uptake of neurodegenerative diseases research results and enhance national and international research collaborations; • Facilitate and support engagement of persons with neurodegenerative diseases affecting cognition and care partners to be actively involved throughout the research process; • Scope and solidify CCNA’s strategic vision in line with the uniqueness of its data; • Optimize systems and mechanisms ensuring increased awareness of, and responsible and timely access to CCNA data and biospecimens, while meeting ethical standards and protecting the privacy of participants; and, • Enhance national and international research collaborations through data and KM linkages with other entities and/or research platforms, such as the CLSA.